LONDON, Sept. 26 – For the past few years, European venture capital firms have been hustling to catch up with their American counterparts, establishing life science divisions and stepping up their investments in biotechnology companies.

Yet despite the enthusiasm for downstream companies promising novel medical technologies and treatments, European investors remain skittish about genomics and proteomics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.